ストックスクリーナーアプリを入手
8.11
4.14%
-0.35
前日終値:
$8.46
開ける：
$8.47
24時間の取引高:
158.56K
Relative Volume:
0.75
時価総額：
$282.90M
収益：
$7,000
当期純損益:
$-41.54M
株価収益率:
-8.7298
EPS:
-0.929
ネットキャッシュフロー:
$-20.57M
1週間 パフォーマンス:
-8.57%
1か月 パフォーマンス:
-26.54%
6か月 パフォーマンス:
-39.75%
1年 パフォーマンス:
-48.34%
1日の値動き範囲:
$8.06
$8.47
1週間の範囲:
$8.06
$9.25
52週間の値動き範囲:
$8.06
$16.76
Benitec Biopharma Inc Stock (BNTC) Company Profile
Compare BNTC vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
8.11 | 282.90M | 7,000 | -41.54M | -20.57M | -0.929 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-07-28 | 開始されました | Wedbush | Outperform |
| 2026-06-10 | ダウングレード | Guggenheim | Buy → Neutral |
| 2026-05-12 | 開始されました | Evercore ISI | Outperform |
| 2025-07-07 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-09-12 | 開始されました | Guggenheim | Buy |
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-06-13 | 開始されました | Piper Sandler | Overweight |
| 2020-10-05 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-02-26 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-31 | 繰り返されました | Maxim Group | Buy |
| 2015-09-16 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Benitec Biopharma Inc (BNTC) 最新ニュース
Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC) - The Globe and Mail
Form 8K Benitec Biopharma Ltd ADR For: 24 September By Investing.com - Investing.com India
An auditor in place since 2020 is out at Benitec Biopharma (BNTC). Ernst & Young is named, pending acceptance. - Stock Titan
Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire
Benitec Biopharma FY 2026 Earnings: Revenue Flat at $0, Net Loss Widens to $45.5 Million - Sci-Tech Today
Benitec Biopharma (NASDAQ: BNTC) Reports $180M Cash Reserves as BB-301 Trial Progresses Toward 2027 Milestone - Kalkine Media
Benitec (NASDAQ: BNTC) prepares $200M shelf that may back its lead gene therapy - Stock Titan
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update - GlobeNewswire
Benitec Biopharma Files $200 Million Shelf Registration - Yahoo Finance
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Enterprise value to revenue forward of Benitec Biopharma Inc. – NASDAQ:BNTC - TradingView
Benitec Biopharma Inc.ADR Peer Comparison – Compare with Others - Value Research
Benitec Biopharma Inc.ADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Benitec (BNTC) Trading: Moves 5.71% Lower to $12.71 for the Current Session; Next Session: the $12.07 to $13.35 Range Remains in Focus in the Latest ReadingBuffered ETF - vinanet.vn
Benitec (BNTC) Levels: Posts a 4.33% Loss to $12.80 in the Latest Session; Current Setup: Price Remains Between $12.16 Support and $13.44 Resistance at the CloseVolume Spike Alerts - vinanet.vn
Benitec (BNTC) Earnings Update: The EPS Result Is Above Expectation for the Current Session; Price Reaction: The Market Price Advances 3.88% in the Latest ReadingLow Growth Earnings - vinanet.vn
Benitec (BNTC) EPS and Revenue: EPS Beats Its Estimate in Latest Trading; Latest Reaction: Shares Close 1.45% Lower on the DayPeak Earnings Alert - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
Trading Systems Reacting to (BNTC) Volatility - Stock Traders Daily
BNTC Q2 2026 Earnings: Loss Narrows More Than Expected as EPS Beats Estimates by 14%Profit Guidance Range - vinanet.vn
Benitec Biopharma (BNTC) Advances 3% as Shares Test Key Resistance LevelUnusual Call Volume - Vinanet
Benitec Biopharma (BNTC) Advances 3% as Shares Test Key Resistance LevelTechnical Analysis - siam.in
BNTC Q2 2026 Earnings: EPS Beats Estimates Despite Revenue Absence and Share DeclineEarnings Growth Analysis - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above 50 Day Moving AverageTime to Sell? - marketbeat.com
Companies Like Benitec Biopharma (NASDAQ:BNTC) Can Afford To Invest In Growth - moomoo.com
Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Sahm
Benitec Biopharma Inc (BNTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
How Benitec Biopharma Inc. (BNTC) Affects Rotational Strategy Timing - Stock Traders Daily
Benitec Biopharma (BNTC) Slips 1.26% as Shares Test Key Support at $11.12Factor Crowding - dars.gov.et
Benitec Biopharma (BNTC) Slips 1.26% as Shares Test Key Support at $11.12Ichimoku Kumo Break - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
BNTC Initiated by Wedbush -- Rating Set to Outperform with PT at $16.00 - GuruFocus
BNTC Initiated by Wedbush -- Rating Set to Outperform with PT at $16.00 - GuruFocus
Wedbush Initiates Coverage on Benitec Biopharma (BNTC) with Outp - GuruFocus
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Benitec Biopharma Inc (BNTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Benitec Biopharma Inc (BNTC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.710|Chg%:+0.240 - TradingKey
Benitec Biopharma Inc (BNTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BNTC|Benitec Biopharma Inc|Price:11.540|Chg%:+0.070 - TradingKey
TradingKey - TradingKey
Benitec Biopharma Inc (BNTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BNTC Q2 2026 Earnings: EPS Beats Estimates Despite No Revenue, Shares Edge HigherProfit Margin Analysis - Vinanet
BNTC|Benitec Biopharma Inc|Price:11.470|Chg%:+0.030 - TradingKey
Benitec Biopharma Inc (BNTC) Institutional Confidence - TradingKey
Benitec Biopharma Inc (BNTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
(BNTC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
(BNTC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Benitec Biopharma (BNTC) Retraces 1.72% – Navigating Key Support and Resistance LevelsIV Crush Alert - vinanet.vn
Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Benitec Biopharma Inc (BNTC) 財務データ
収益
当期純利益
現金流量
EPS
Benitec Biopharma Inc (BNTC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 26 '25 |
Buy |
13.10 |
16,836 |
220,552 |
9,634,395 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '25 |
Buy |
12.85 |
50,000 |
642,500 |
9,620,075 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 22 '25 |
Buy |
12.08 |
19,542 |
236,067 |
9,577,475 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 19 '25 |
Buy |
11.48 |
16,384 |
188,088 |
9,560,825 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 18 '25 |
Buy |
11.24 |
10,215 |
114,817 |
9,546,875 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 07 '25 |
Buy |
13.50 |
1,481,481 |
19,999,994 |
9,538,175 |
4.22%
大文字化:
|
ボリューム (24 時間):